VEGF, flt-1, and KDR/flk-1 as Prognostic Indicators in Endometrial Carcinoma

By Fine B.A.   Valente P.T.   Feinstein G.I.   Dey T.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite

TNP-470 suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells

By Kaya Mitsunori   Wada Takuro   Nagoya Satoshi   Kawaguchi Satoshi   Yamashita Toshihiko   Yamamoto Nobuyuki   Yoshimoto Mitsunori   Okada Futoshi   Ishii Seiichi  

Sarcoma, Vol. 5, Iss. 4, 2001-12 ,pp. : 197-202

Informa Healthcare

Access to resources Recommend Favorite

Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP-470 on human breast cancer cells

By Yamamoto D.  

Breast Cancer Research and Treatment, Vol. 55, Iss. 2, 1999-05 ,pp. : 147-158

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

By Witte L.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

MMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting αvβ3-mediated SDF-1/CXCR4 signaling

By        

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1279-1288

Spandidos Publications

Access to resources Recommend Favorite